The influence of inhaler selection on efficacy of asthma therapies (Q35169765)

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Effect of solution and suspension type aerosol of formoterol on tremor response and airways in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Variability of aerosol delivery via spacer devices in young asthmatic children in daily life

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Review of therapeutically equivalent alternatives to short acting beta(2) adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Trials to assess equivalence: the importance of rigorous methods

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A comparison of terbutaline inhaled by Turbuhaler and by a chlorofluorocarbon (CFC) inhaler in children with exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Bioequivalence of metered-dose inhaled medications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Therapeutic equivalence of inhaled salbutamol

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Dose-response of inhaled drugs in asthma. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

The use of inhaled corticosteroids in adults with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Importance of the inhalation device on the effect of budesonide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Measurement of particle size characteristics of metered dose inhaler (MDI) aerosols

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Drug delivery characteristics of metered-dose inhalers.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Factors affecting total and "respirable" dose delivered by a salbutamol metered dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Low first-spray drug content in albuterol metered-dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Test method for evaluation of loss of prime in metered-dose aerosols

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Cooling of metered-dose inhalers decreases pressure output from canisters

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Lung bioavailability of generic and innovator salbutamol metered dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

High speed photographic analysis of aerosols produced by metered dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Bronchodilator delivery from Gentlehaler, a new low-velocity pressurized aerosol inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

The Spacehaler for delivery of salbutamol: a comparison with the standard metered-dose inhaler plus Volumatic spacer device

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Pharmaceutical transition to non-CFC pressurized metered dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

The use of reservoir devices for the simultaneous delivery of two metered-dose aerosols

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Optimum use of a spacer device

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Drug delivery from holding chambers with attached facemask

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Volumatic usage: some generic salbutamol metered dose inhalers can be used

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Inhalational drug delivery from seven different spacer devices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Choosing the metered-dose inhaler spacer or holding chamber that matches the patient's need: evidence that the specific drug being delivered is an important consideration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Influence of spacer device on drug delivery to young children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

In vitro comparison of salbutamol hydrofluoroalkane (Airomir) metered dose inhaler aerosols inhaled during pediatric tidal breathing from five valved holding chambers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

In vitro performance testing of three small volume-holding chambers under conditions that correspond with use by infants and small children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

In vitro comparison of beclomethasone and salbutamol metered-dose inhaler aerosols inhaled during pediatric tidal breathing from four valved holding chambers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A comparative analysis of the particle size output of beclomethasone diproprionate, salmeterol xinafoate and fluticasone propionate metered dose inhalers used with the Babyhaler, Volumatic and Aerochamber spacer devices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

In vitro performance of three combinations of spacers and pressurized metered dose inhalers for treatment in children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Electrostatic charge on a plastic spacer device influences the delivery of salbutamol

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A non-electrostatic spacer for aerosol delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Use of 'Nebuhaler' and face-mask in young asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Measuring total and regional lung deposition using inhaled radiotracers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Pulmonary delivery of peptide drugs: effect of particle size on bioavailability of leuprolide acetate in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Fractional deposition from a jet nebulizer: how it differs from a metered dose inhaler.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

In vitro, ex vivo, in vivo veritas

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers--implications for in vitro testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

In vitro properties of pressurized metered dose inhalers with and without spacer devices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Aerosol particle generation from dry powder inhalers: can they equal pressurized metered dose inhalers?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

The twin impinger: a simple device for assessing the delivery of drugs from metered dose pressurized aerosol inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A cascade impactor entry port for MDI sprays with collection characteristics imitating a physical model of the human throat

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

High-percentage lung delivery in children from detergent-treated spacers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Effect of add-on devices for aerosol drug delivery: deposition studies and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Effect of electrostatic charge in plastic spacers on the lung delivery of HFA-salbutamol in children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Reducing electrostatic charge on spacer devices and bronchodilator response

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Randomised controlled study of clinical efficacy of spacer therapy in asthma with regard to electrostatic charge

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Holding chambers versus nebulisers for beta-agonist treatment of acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Clinical evaluation of a simple demand inhalation MDI aerosol delivery device

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A comparison of two delivery methods for aerosolized metaproterenol sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of metered-dose inhaler attached to an Aerochamber with an updraft nebulizer for the administration of metaproterenol in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Evaluation of aerosol drug output from the OptiChamber and AeroChamber spacers in a model system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Drug delivery in asthma: a comparison of spacers with a jet nebuliser

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Babyhaler--a new paediatric aerosol device

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Delivery of salbutamol by metered dose inhaler and valved spacer to wheezy infants: effect on bronchial responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Short-term Effect of Albuterol, Delivered via a New Auxiliary Device, in Wheezy Infants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A new baby-spacer device for aerosolized bronchodilator administration in infants with bronchopulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Protective effect of albuterol delivered via a spacer device (Babyhaler) against methacholine induced bronchoconstriction in young wheezy children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Airway responsiveness in wheezy infants: evidence for functional beta adrenergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of three techniques of inhalation on the airway response to terbutaline

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Improvement of pressurised aerosol deposition with Nebuhaler spacer device

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Bronchodilation of terbutaline in small doses from a 750 ml spacer. A cumulative dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Childhood Asthma: Improved Efficacy of Pressurized Terbutaline Aerosol by Use of a 750-ml Spacer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

1 reference

7 January 2021

Single breath versus panting technique in salbutamol delivery through a 750 mL spacing device

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Inhaled budesonide for chronic wheezing under 18 months of age

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Use of budesonide in severe asthmatics aged 1-3 years

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Potential limitations of a conical spacer device in severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Salbutamol aerosol causes a tachycardia due to the inhaled rather than the swallowed fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol. Influence of mouth rinsing and gargling

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Inhaled corticosteroids: benefits and risks

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

New perspectives on inhaled drug delivery and systemic bioactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Establishing a therapeutic index for the inhaled corticosteroids: part I. Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Benefits and risks of inhaled glucocorticoids in children with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Morning serum cortisol concentrations after 2 mg inhaled beclomethasone dipropionate in normal subjects: effect of a 750 ml spacing device

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A large volume spacer significantly reduces the effect of inhaled steroids on bone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Evaluation of inhalation aids of metered dose inhalers in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Use of pressurised aerosols by asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Errors in inhalation technique and efficiency in inhaler use in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

An assessment of a new breath actuated inhaler device in acutely wheezy children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A device for overcoming discoordination with metered-dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A comparative study of the efficacy of beclomethasone dipropionate delivered from a breath activated and conventional metered dose inhaler in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparative assessment of a new breath-actuated inhaler in patients with reversible airways obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Effectiveness of Inhaled Bronchodilator Delivery Systems for Elderly Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

What determines whether an elderly patient can use a metered dose inhaler correctly?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

[Evaluation of the ability of asthmatic children to use a breath-actuated pressurized inhaler]

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Beclomethasone dipropionate in asthma: a comparison of two methods of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Long-term comparison of salbutamol powder with salbutamol aerosol in asthmatic out-patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Albuterol treatment for children with asthma: a comparison of inhaled powder and aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of inhaled albuterol powder and aerosol in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Salbutamol by powder or spray inhalation in childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Dry powder inhalers are bioequivalent to metered-dose inhalers. A study using a new urinary albuterol (salbutamol) assay technique

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Bronchodilator responses to salbutamol using diskhaler versus metered-dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

The inhalation device influences lung deposition and bronchodilating effect of terbutaline

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Equivalent Bronchodilation with Salbutamol Given via pMDI or Turbuhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Terbutaline via pressurised metered dose inhaled (P-MDI) and Turbuhaler in highly reactive asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Variability in lung deposition of inhaled drug, within and between asthmatic patients, with a pMDI and a dry powder inhaler, Turbuhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Influence of inspiratory capacity on bronchodilatation via Turbuhaler® or pressurized metered-dose inhaler in asthmatic children: a comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A double-blind comparison between a new multidose powder inhaler (Turbuhaler) and metered dose inhaler in children with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A comparison of the bronchodilatory effect of 50 and 100 microg salbutamol via Turbuhaler and 100 microg salbutamol via pressurized metered dose inhaler in children with stable asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of a new multidose powder inhaler with a pressurized aerosol in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Easyhaler, a novel multiple dose powder inhaler: clinically equivalent to salbutamol metered dose inhaler and easier to use

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Clickhaler (a novel dry powder inhaler) provides similar bronchodilation to pressurized metered-dose inhaler, even at low flow rates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Dose response to inhaled terbutaline powder and peak inspiratory flow through Turbuhaler in children with mild to moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Drug delivery from the Turbuhaler and Nebuhaler pressurized metered dose inhaler to various age groups of children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of inhaled terbutaline administered by either the Turbuhaler dry powder inhaler or a metered-dose inhaler with spacer in preschool children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Treatment of asthma in pre-school children with inhalation of terbutaline in Turbuhaler compared with Nebuhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A comparison of the lung deposition of budesonide from Easyhaler, Turbuhaler and pMDI plus spacer in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Pulmonary deposition and clinical response of 99mTc-labelled salbutamol delivered from a novel multiple dose powder inhaler.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Application and efficacy of the multi-dose powder inhaler, Easyhaler, in children with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A new beclomethasone dipropionate multidose powder inhaler in the treatment of bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Equivalence of two steroid-containing inhalers: easyhaler multidose powder inhaler compared with conventional aerosol with large-volume spacer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Salbutamol dry powder inhaler: efficacy, tolerability, and acceptability study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of DiskusTMInhaler, a New Multidose Powder Inhaler, with DiskhalerTMInhaler for the Delivery of Salmeterol to Asthmatic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Prevention of exercise-induced bronchospasm in pediatric asthma patients: A comparison of two salmeterol powder delivery devices.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A critical comparison of the dose delivery characteristics of four alternative inhalation devices delivering salbutamol: pressurized metered dose inhaler, Diskus inhaler, Diskhaler inhaler, and Turbuhaler inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of a new multidose powder inhaler (Diskus/Accuhaler) and the Turbuhaler regarding preference and ease of use

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Fluticasone propionate--an update on preclinical and clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparative lung delivery of salbutamol given via Turbuhaler and Diskus dry powder inhaler devices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Equivalent therapeutic ratio of salbutamol given by Turbuhaler®and Diskus™

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of two budesonide powder inhalers, Easyhaler and Turbuhaler, in steroid-naïve asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Metered-dose inhalers and nebulizers in the acute setting

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Pulmonary response to a bronchodilator delivered from three inhalation devices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of a hand-held nebulizer with a metered dose inhaler-spacer combination in acute obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

An open, prospective comparison of beta 2 agonists given via nebuliser, Nebuhaler, or pressurised inhaler by ambulance crew as emergency treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Treatment of acute asthma: salbutamol via jet nebuliser vs spacer and metered dose inhaler.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Substitution of metered-dose inhalers for hand-held nebulizers. Success and cost savings in a large, acute-care hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Stratospheric sink for chlorofluoromethanes: chlorine atom-catalysed destruction of ozone

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Metered-dose inhalers and CFCs: what respiratory physicians need to know

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparable bronchodilation with hydrofluoroalkane-134a (HFA) albuterol and chlorofluorocarbons-11/12 (CFC) albuterol in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of non-chlorofluorocarbon-containing salbutamol and conventional inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Improved delivery of inhaled steroids to the large and small airways

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Therapeutic ratio of hydrofluoroalkane and chlorofluorocarbon formulations of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Poor inhalation technique, even after inhalation instructions, in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Is the correct use of a dry powder inhaler (Turbohaler) age dependent?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Influence of inspiratory flow rate upon the effect of a Turbuhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

How to choose delivery devices for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Asthma drug delivery devices for children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Psychological factors associated with medication nonadherence in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Noncompliance and treatment failure in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Measuring compliance with inhaled medication in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Compliance with inhaled asthma medication in preschool children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Asthma drug adherence in a long term clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Patient satisfaction with the Diskhaler® and the Diskus® inhaler, a new multidose powder delivery system for the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Importance of selected inhaler characteristics and acceptance of a new breath-actuated powder inhalation device

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Pressurised aerosol deposition in the human lung with and without an "open" spacer device

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Scintigraphic assessment of drug delivery from the Ultrahaler dry powder inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Efficient delivery to the lungs of flunisolide aerosol from a new portable hand-held multidose nebulizer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Delivery of propellant soluble drug from a metered dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Deposition of fenoterol from pressurized metered dose inhalers containing hydrofluoroalkanes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Improved targeting of beclomethasone diproprionate (250 micrograms metered dose inhaler) to the lungs of asthmatics with the Spacehaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Deposition and pharmacokinetics of an HFA formulation of triamcinolone acetonide delivered by pressurized metered dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of beclomethasone dipropionate delivery by easyhaler dry powder inhaler and pMDI plus large volume spacer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Pressurised aerosol with conical spacer is an effective alternative to nebuliser in chronic stable asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Cumulative dose-response study comparing terbutaline pressurized aerosol administered via a pearshaped spacer and terbutaline in a nebulized solution

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparative efficacy of different methods of nebulising terbutaline

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Terbutaline aerosol from a metered dose inhaler with a 750-ml spacer or as a nebulized solution. Comparison of two delivery systems for bronchodilator aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

High-dose inhaled terbutaline in the management of chronic severe asthma: comparison of wet nebulisation and tube-spacer delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Aerosol bronchodilator delivery methods. Relative impact on pulmonary function and cost of respiratory care

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Terbutaline aerosol given through pear spacer in acute severe asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Aerosolized metaproterenol in the treatment of asthmatics with severe airflow obstruction. Comparison of two delivery methods

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Metered dose inhaler and nebuliser in acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Randomised trial spacer v nebuliser for acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Wet nebulizer versus spacer and metered dose inhaler via tidal breathing

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Comparison of beta-adrenergic agents delivered by nebulizer vs metered dose inhaler with InspirEase in hospitalized asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Bronchodilatation with a metered-dose inhaler plus an extension, using tidal breathing vs jet nebulization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021

Metered-dose inhalers with spacers vs nebulizers for pediatric asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900083-8

7 January 2021